Business description
DocMorris AG is one of Europe's leading online pharmacy and one of Switzerland's foremost wholesale suppliers to medical practitioners. With its business model, it offers high-quality, safe and cost-effective pharmaceutical care and thus contributes to reducing healthcare costs. It is also characterized by the continuous further development of digital services in the field of drug management in order to increase therapy safety. The creation of added value and a pronounced patient orientation company as an important strategic partner for service providers, cost units and industry.
Management board & Supervisory board
| CEO |
| Walter Hess |
| Management board |
| Daniel Wüest, Madhu Nutakki, Kaspar Niklaus, David Masó |
| Supervisory board |
| Walter Oberhänsli, Prof. Stefan Feuerstein, Prof. Dr. Andréa Belliger, Rongrong Hu, Dr. Christian Mielsch, Florian Seubert |
Company data
| Name: |
DocMorris AG |
| Address: |
Walzmühlestrasse 49,CH-8500 Frauenfeld |
| Phone: |
- |
| Fax: |
- |
| E-mail: |
-
|
| Internet: |
https://corporate.docmorris.com/de/ |
| Industry: |
Consumer Goods |
| Sector: |
Retailers |
| Sub sector: |
- |
| End of financial year: |
12-31 |
| Free Float: |
- |
| IPO date: |
2017-07-06 |
Investor relations
| Name: |
Dr. Daniel Grigat |
| IR phone: |
+41 52 560 58 10 |
| IR Fax: |
- |
| IR e-mail: |
ir@docmorris.com
|
